Lung Cancer

Pembrolizumab as First-Line Therapy in Metastatic NSCLC: Practice-Changing Implications of KEYNOTE-024 Trial

We are in the midst of a paradigm shift in lung cancer. In the past 2 years, the anti–programmed cell death protein 1 (anti–PD-1) inhibitors...

Kidney Cancer

Vaccine Therapy in Metastatic Renal Cell Carcinoma: Past, Present, and Future

As reviewed in this issue of The ASCO PostBrian Rini, MD, and colleagues recently reported results from the phase III IMPRINT trial,1 which...

Palliative Care

How Video Support Tools Help Patients Make Informed Decisions About End-of-Life Care

A relatively recent study by Areej El-Jawahri, MD, and her colleagues is showing how the use of visual media can empower patients with advanced cancer, as well as other life-threatening...


More Top Stories

Lung Cancer

Tony Mok, MD, on NSCLC: Results of the IMPRESS Study

Conquer Cancer Foundation’s International Programs

Did you know the Conquer Cancer Foundation of ASCO (CCF) has provided funding for cancer research in 68 countries? In more than 33 years, over 1,700 grants and awards totaling $105 million have been given out by CCF worldwide.

CCF grants and awards support clinical and translational cancer...


Psychotropic and Opioid Medication Use in Older Patients With Breast Cancer Across the Care Trajectory

A new McGill University study published by Syrowatka et al in JNCCN – Journal of the National Comprehensive Cancer Network found that most patients with breast cancer aged 65 and older use psychotropic and opioid medications during active treatment, often in the first year of...


Teresa Calimeri, MD, PhD, on DLBCL: Findings on High-Dose Methotrexate (Italian Language Version)

Bladder Cancer

Development and Validation of a Quality Assurance Score for Robot-Assisted Radical Cystectomy

What are the factors that add up to the best outcomes for patients who have surgery to treat cancer? Looking for a better way to measure quality of care and share best practices in surgical oncology, a team from Roswell Park Cancer Institute developed a quality assessment tool and validated it in a ...

CancerLinQ™ Platform Hits Milestone of Having More Than 1 Million Patient Records in System

CancerLinQ LLC, a wholly owned nonprofit of ASCO, announced on October 20, 2016, that more than 1 million patient records are now in the CancerLinQ™ platform. In addition, 70 practices have signed agreements to participate in CancerLinQ, representing more than 1,500 oncologists.

“We are excited to ...

Having a Child With Cancer May Adversely Affect Parents’ Income and Employment

Having a child with cancer led to income reductions for parents and job discontinuation among mothers in a recent study, even after adjusting for prediagnosis sociodemographic factors. Published by Norberg et al in Cancer, the findings indicate that childhood cancer affects parents' income and...

Solid Tumors

Janessa J. Laskin, MD, on Tumor Gene Expression and Advanced Cancers

Dana-Farber Cancer Institute, CPDC at McMaster University Join to Speed Cancer Research With Molecular Probes

Dana-Farber Cancer Institute and the Centre for Probe Development and Commercialization (CPDC) at McMaster University in Hamilton, Ontario, Canada, will work together to create novel molecular probes for noninvasive imaging in cancer research, drug development, and patient care.

The two leading...


Assessment of Therapeutic Response by Intrinsic Subtype for HER2-Positive Breast Tumors

In an analysis of outcomes in the North Central Cancer Treatment Group/Alliance N9831 trial reported in the Journal of the National Cancer Institute, Perez et al found that patients with tumors scored as HER2-enriched or luminal subtype derived a recurrence-free survival benefit from the addition...

click me